Age-related Macular Degeneration Market
According to Intent Market Research, the Age-related Macular Degeneration Market is expected to grow from USD 8.4 billion in 2023 at a CAGR of 8.9% to touch USD 15.3 billion by 2030. The Age-related Macular Degeneration Market is dominated by key players such as AbbVie, Allergan (AbbVie), Apellis Pharmaceuticals, Bayer, Biogen, Genentech (Roche), Neovasc, Novartis, Ocular Therapeutix, Regeneron Pharmaceuticals, Roche, Senju Pharmaceutical and ThromboGenics.